Ann Transplant Res | Volume 2, Issue 1 | Case Report | Open Access

Posterior Reversible Encephalopathy Syndrome: A Reversible Tacrolimus Induced Neurotoxicity in a Heart Transplant Recipient - A Case Report

Anantharaman R*, Vivek M, Madhusankar N, Arulkumar A and Cherian KM

Department of Cardiology, Frontier Lifeline Hospital, India

*Correspondance to: Anantharaman R 

Fulltext PDF

Abstract

Tacrolimus is widely used immunosuppressive drug following heart transplantation. Mild to severe form of neurological symptoms are known to occur with use of Tacrolimus. Posterior Reversible Encephalopathy Syndrome (PRES) is one such manifestation, which can present with multitude of neurological symptoms. We report a case of PRES in a heart transplant recipient receiving Tacrolimus.

Keywords:

Tacrolimus; Heart transplant; Posterior reversible encephalopathy syndrome

Citation:

Anantharaman R, Vivek M, Madhusankar N, Arulkumar A, Cherian KM. Posterior Reversible Encephalopathy Syndrome: A Reversible Tacrolimus Induced Neurotoxicity in a Heart Transplant Recipient- A Case Report. Ann Transplant Res. 2018;1(2):1010.

Subscribe to Our Newsletter